Edition:
United Kingdom

People: Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

23.30CHF
16 Aug 2019
Change (% chg)

CHF0.80 (+3.56%)
Prev Close
CHF22.50
Open
CHF22.54
Day's High
CHF23.32
Day's Low
CHF22.52
Volume
502,071
Avg. Vol
321,011
52-wk High
CHF25.02
52-wk Low
CHF15.20

Clozel, Martine 

Ms. Martine Clozel is Executive Vice President, Chief Scientific Officer, Member of the Executive Board at Idorsia Ltd. She joined Idorsia from Actelion, which she co-founded in 1997. Previously, Ms. Clozel spent 11 years at F. Hoffmann-La Roche Ltd, where she initiated the research project on endothelin and endothelin receptor antagonists. Ms. Clozel is a pediatrician specializing in neonatal intensive care, has an MD degree from Nancy University, France, and received further training in physiology and pharmacology from McGill University, Montreal, Canada and the University of California, San Francisco, U.S.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --